13F-HR filed by Allostery Investments LP
Allostery Investments LP filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-14, with 20 holding rows worth $7,850,255.
- Accession
- 0001013594-25-001022
- Filer
- CIK 1978599
- Filed
- 2025-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2025
A holdings report, 20 entries on the cover page, a total value of $7,850,255 stated on the cover page (in dollars after the unit check, H1), rows summing to $7,850,256 with VALUE read as dollars as filed, 13F file number 028-25258. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 167,350 | $1,280,228 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 22,500 | $1,200,600 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 120,119 | $769,963 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 52,500 | $689,850 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 60,000 | $552,600 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 119,294 | $532,051 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 9,000 | $473,400 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 40,000 | $452,200 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 40,353 | $277,629 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 6,000 | $260,580 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 2,500 | $236,450 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 40,000 | $204,800 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 4,000 | $172,720 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 5,000 | $165,200 | dollars as filed | |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 9,356 | $149,602 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 4,000 | $141,960 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 4,000 | $103,360 | dollars as filed | |
| PROMIS NEUROSCIENCES INC | 74346M406 | COM NEW | 155,720 | $76,303 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 1,000 | $65,850 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 9,000 | $44,910 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001013594-25-001022 | this filing | 2025-08-14 | acceptance time not in the bulk data set |